PATIENT CASE HISTORY. General Health Medications Allergies

Size: px
Start display at page:

Download "PATIENT CASE HISTORY. General Health Medications Allergies"

Transcription

1 OCULAR PHARMACOLOGY What I Need to Know Before I Medicate A Patient Lynn Lawrence, CPOT, ABOC, COA, OSC ROLE of the ASSISTANT AND TECHNICIAN Accurate documentation/recording Patient Education can assist in preventing mistakes NEVER Work in Doubt! Read and re-read the medication request Be careful with hand-offs! The Medication Check For Ophthalmic Use, must be on the container Check name Check dosage Check expiration date Check for contamination The Patient Checks Reason for visit Check patient s current health condition Verify patient allergies Provider medication request Check visual acuity Check IOP Check the patients angles Do not leave the patient unattended and routinely monitor PATIENT CASE HISTORY The best way to prevent an adverse reaction is to perform an excellent case Hx? General Health Medications Allergies Application Procedures Wash hands thoroughly before administration Give medications with patient in lying position Tilt head backward or lie down and gaze upward Gently grasp lower eyelid below eyelashes and pull the eyelid away from the eye to form a pouch Place dropper directly over the eye. Avoid contact of the dropper with the eye, finger or any other surface Release the lid slowly and close the eye Occlude puncta for 2-3 minutes Wait 5 minutes before administering a second medication or drop 1

2 Preparation 1. Wash your hands. 2. Triple check the medication you are going to instill to ensure it is what the doctor ordered. 3. Advise the patient of what you are going to do. 4. Recline the patient or gently tilt the patient s head back. Always ask the patient about neck or back problems before tilting his or her head. Do not tilt a Down s syndrome patient s neck due to the high risk of cervical fracture. 5. With one hand, hold the upper lid and, with a finger of the other hand (the one holding the little bottle of medication), pull down gently on the lower lid. 6. Have the patient look down. 7. Keep the bottle about ½ above the eye. This should be high enough to avoid contamination by the patient s eyelashes in the event the patient inadvertently blinks, while still allowing good control of where the drop goes. 8.Now, squeeze the bottle to dispense a drop in the eye. Ideally, the drop hits just above the upper limbus, causing minimal reaction by the patient (since the very sensitive cornea isn t hit directly), but allowing a good percentage of medication to flow across the cornea before it gets diluted by tears. CAUTION: Keep the eye dropper tip well away from the eye so, even if the patient blinks, the lashes do not touch it. If the dropper tip comes into contact with the patient s eyes, lids, or lashes, the bottle is considered contaminated and must be thrown away after you finish with the patient. Do not attempt to use it on another patient. Cont 9. Advise the patient not to squeeze his or her eyes tightly closed nor dab his or her eyes with tissue. Squeezing and dabbing eliminates some of the medication from the eye, minimizing the medication s effectiveness. 10. Once the drop is in, plug the punctal area by gently squeezing in the nasal canthus. You are squeezing in the right place if you feel a little bump under your finger tips. If the medication is to be put in both eyes, quickly instill the drop into the second eye, and then perform punctal occlusion to both eyes at the same time. Essentially, you want the eye to absorb all the medicine. You don t want the puncta to suck up the drug and pass it through the canaliculi, into the lacrimal sac, and go down the nasal lacrimal duct into the throat. Eye medications swallowed can affect a patient s heart rate and breathing. You don t want this to happen, so perform punctal occlusion for about one minute after instillation of an eye drop. Attempting to instill an ophthalmic drug into a child s eyes can be challenging. A good method to minimize most problems you have when placing drops in a child s eye is to lay the child back and ask the child to close both eyes. Put one drop of the ophthalmic drug in each medial canthal area. Have the child blink once or twice, and the task is done with little or no fuss. Don t forget to do the punctal occlusion to minimize systemic absorption. Instilling an ointment is essentially the same, except the ointment is squeezed into the lower conjunctival sac until a ¼ -worth is administered. Punctal occlusion is unnecessary. As with drops, do not allow the medication dispenser to touch the patient or it is considered contaminated. 2

3 Dilation Hazards Cross Contamination Narrow anterior chamber angle Potential risk in dilating opt vs oph CLINICAL ADMINISTRATION Patient History Clinical Procedures Which May Be Influenced by Medications The ERx Option Plan for acute angle glaucoma attack Make sure you are far enough away not to touch the patient Bio-Tissue A medical device used by eye doctors around the world to protect, repair and heal damaged or inflamed eye surfaces Amniotic membrane is part of the placenta. It is the tissue closest to the baby throughout development in the womb. Amniotic membrane protects the baby from any harm and it has natural therapeutic actions which help the baby develop. Methods of medication delivery Ocular medications can be administered in several different ways. Each method has advantages and disadvantages, so the method of medication delivery depends on the desired outcome, type of drug being administered, and type of problem being treated. Primary methods of ocular medication delivery are: - Topical application - Continuous release delivery - Subconjunctival - Sub-tenon s - Retrobulbar - Intravitreal injections The most common method of medication delivery used in the eye clinic is topical application. Ophthalmic Drug Complications Giving people medications may seem routine, but there are possible negative consequences. Not all people are tolerant of all medications. If given a drug they can t tolerate, a patient may have an allergic or toxic reaction. As an eye technician administering drugs to people on a daily basis, it s important you understand and recognize what is occurring if a patient does have a reaction. You also need to understand how drugs affect the body s autonomic nervous system (ANS), to include the sympathetic and parasympathetic divisions. VITAMIN SUPPLEMENTS Not all supplements are the same 3

4 CLASSIFICATIONS Solutions Suspensions Ointments OCULAR ALLERGIES Over the counter medications Artificial Tears Antihistamine Decongestants Corticosteroids DIAGNOSTIC AGENTS Topical Anesthetics Topical Anesthestics Mydriatics Cycloplegics Dyes/Stains Fluress Gonioscopic Solutions Proparacaine Tetracaine Cocaine Mydriatics & Cycloplegics Tropicamide Phenylephrine Cyclogyl Atropine Homatropine Scopalomine Mydriatic Mydriasis is the dilation of the pupils, so, logically, a mydriatic drug causes dilation. The main reason the eyes is dilated is to allow the doctor to perform a thorough exam of the posterior portion of a patient s eyes. A big pupil allows a wider field of view and gives the examiner a chance to see the vast majority of the retina, rather than the very small amount seen in an undilated eye. Mydriasis is also useful in allowing you to take fundus photographs of the macula, optic nerve, and any retinal anomalies present. 4

5 Cycloplegics These drugs cause mydriasis like mydriatics, but they also cause cycloplegia, which is paralysis of the ciliary muscle. Remember, the ciliary muscle controls focusing of the light rays entering the eye by changing the shape of the crystalline lens. Cycloplegics are used in dilating the pupils to facilitate examination of the fundus, prevent ciliary spasm and pain in iritis patients, and prevent a patient (usually a suspected hyperope) from constantly accommodating while the doctor is trying to refract the patient and figure out the prescription. Cycloplegics are also used to perform entrance eye exams on flyers to find what their true refractive error is. Again, this is accomplished by paralyzing the focusing mechanism of the eyes (temporarily) while the doctor refracts the patient. Cycloplegics almost always come in bottles with red caps. Tropicamide (Mydriacyl ; Opticyl ) The information you need to know about tropicamide is: Preparation: Solution, percent (most common usage is 1 percent). Dosage: Instill one drop in each eye. Repeat if the doctor requests it. Action and uses: Produces mydriasis and cycloplegia. Onset of action is rapid (20 30 mins) and duration varies from one-half to four hours. Used primarily in conjunction with phenylephrine when dilating patients for routine fundus exams. GLAUCOMA MANAGEMENT Gonioscopy Solutions Pilocarpine Beta-Blockers Carbonic Anhydrase Inhibitors Adrenergic Agonists These are use in Gonioscopy Goniosol Gonioscopic Celluvisc Beta Blockers Beta Blockers Beta-blockers are the current drugs of choice in lowering IOP. Timoptic, Betoptic, and Betagan are some of the most popular drugs being used to lower IOP today. Introduced in the late 1970s, they quickly became the initial drug of choice for lowering IOP. One reason beta-blockers are so popular is, on average, they reduce IOP by 25 percent. Another reason is they can be used once or twice daily, unlike most previous medications that were used up to four times a day. Finally, most of the previous drugs used to lower IOP caused miosis (pupillary constriction), dim vision (due to constricted pupil size), eyebrow ache, and stimulation of accommodation (which can blur vision). Fortunately, beta-blockers work without these side effects. However, this does not mean they are perfect, as they also have some side effects. Beta-blockers block the beta 1 and beta 2 receptors from doing their jobs in the body. This is good Thus, patients with certain systemic diseases warrant special consideration by a doctor trying to decide whether the person should use beta-blockers or not. The following is a very general list of systemic conditions contraindicating betablocking medication usage. Asthma. Heart or circulatory problems. Chronic obstructive pulmonary disease (COPD). 5

6 Cap Color Drug Class CAP Colors Tan Antibiotics, Antivirals, Antifungals In addition, patients already on systemic beta-blockers (e.g., Inderal for high blood pressure) should be considered highrisk candidates for use of any of the beta-blocker medications. Patients may be better off using one of the cholinergic medications, carbonic anhydrase inhibitors, or prostaglandin inhibitors instead. Some of the common side effects of beta-blockers (especially the more medication the patient systemically absorbs) are: Bradycardia the slowing down of the heart rhythm (leading to low blood pressure and dizziness). Induced asthma. Mood changes. Pink Red Grey Green Yellow or Blue Purple Orange Turquoise Anti-inflammatory/Steroids treats allergic reactions, swelling, redness (slows healing can cause cataracts and glaucoma). Do not use on fungal infections Mydriatics/Cycloplegics (dilate pupil) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) control inflammation caused by ocular allergies without steroidal sideeffects Miotics (stimulates sphincter and causes pupil constriction) Beta-Blockers traditionally used to treat glaucoma, reduce IOP by decreasing aqueous humor Adrenic Agonists (reduce IOP) Carbonic Anhydrase Inhibitors (reduce IOP) Prostaglandin Analogues (reduce IOP by increasing aqueous outflow) Dyes & Stains Fluorescein Rose Bengal Lissamine Green Fluress OCULAR SURFACE Artificial Tears Different ingredients Allergies Lubricating Ointments Punctal Occlusion CLINICAL ADMINISTRATION Patient History Clinical Procedures Which May Be Influenced by Medications Antibiotic Biotic means relating to, produced by, or caused by living organisms The prefix anti "against" the referent of the stem to which the prefix is affixed 6

7 THERAPEUTIC AGENTS OCULAR INFLAMMATION Antibiotics Anti-virals Drugs that lower IOP Anti-inflammatory agents Non-Steroidal Combinations Corticosteroids Steroid-Antibiotic Combinations Non-Steroidal Anti-inflammatory Drugs (NSAIDS) Oral Analgesics OCULAR INFECTIONS OCULAR SURFACE Topical Antibiotics Oral Antibiotics Anti-Viral Analgesics Artificial Tears Lubricating Ointments Punctal Occlusion OCULAR ALLERGIES IN-OFFICE PROCEDURES Artificial Tears Antihistamine-Decongestants Corticosteroids 7

8 Patient Instruction- Solutions and Suspensions Wash hands thoroughly before administration Tilt head backward or lie down and gaze upward Gently grasp lower eyelid below eyelashes and pull the eyelid away from the eye to form a pouch Place dropper directly over the eye. Avoid contact of the dropper with the eye, finger or any other surface Release the lid slowly and close the eye Occlude punta for 2-3 minutes Wait 5 minutes before administering a second medication or drop Patient Instruction- Ointment Wash hands thoroughly Tilt head backward or lie down and gaze upward Gently pull down the lower lid to form a pouch Place.25 to.50 inch of ointment with a sweeping motion Close the eye for 1-2 minutes Temporary blurring of vision may occur. Remove excess ointment with a tissue Wait 10 minutes before applying the second ointment Topical application As stated earlier, topical drugs are dropped directly in the eye. Topical medications are chemically designed in four major forms: 1. Solutions are one or more substances dissolved in a liquid medium. They work well, but have minimal contact time with the eye. 2. Suspensions are drops containing finely divided drug particles suspended in a liquid medium. Since the drug is not dissolved into the fluid (the little particles settle at the bottom of the bottle), drugs in suspension must be shaken before use. If they are not shaken, the drug is not distributed evenly and is not very effective. Topical Applications Cont 3. Ointments (abbreviated ung in prescription form) are drugs suspended in a petroleum base. They are a good delivery method as they prolong a drug s contact time with the cornea. On the down side, they smear the cornea with goo and blur vision. Because of this, ointments usually are prescribed for patients to use just before bed. 4. Continuous release delivery is sandwiched in a membrane. The membrane is placed inside the lower conjunctival sac, where it dissolves throughout the day, releasing medication to the eye. Continuous release delivery is actually a separate system, but is included here since it occurs topically. Continuous release delivery A medication device placed in the eye, in the conjunctiva and lasting for a week is quite a benefit to patients who have trouble keeping up with their drops. The most common of these devices is the Pilocarpine Ocusert, which permits continuous delivery of medication 24 hours a day for seven days. Subconjunctival injections Injections may be administered under the conjunctiva to deliver medications in large doses and longer durations (fig. 4 4). The subconjunctival medication gains access to the eye by absorption into the bloodstream through the episcleral and conjunctival vessels. Subconjunctival injections are used primarily in the treatment of intraocular infection or acute uveitis cases. 8

9 Ophthalmic Drug Complications Giving people medications may seem routine, but there are possible negative consequences. Not all people are tolerant of all medications. If given a drug they can t tolerate, a patient may have an allergic or toxic reaction. As an eye technician administering drugs to people on a daily basis, it s important you understand and recognize what is occurring if a patient does have a reaction. You also need to understand how drugs affect the body s autonomic nervous system (ANS), to include the sympathetic and parasympathetic divisions. Allergic Reaction An allergic response is the most frequent type of drug reaction. Signs and symptoms vary from moderate swelling and redness (most common) to convulsions and death (less common). Because of the wide range of symptoms possible, recognition of a drug reaction is based on the degree and type of change the patient has as a result of the administration of a drug. Allergic reactions usually follow repeated application of a medication, since the patient must be exposed to the agent to develop a hypersensitivity to it. Thus, a delay in time occurs between the reaction to a particular drug and the development of a hypersensitivity state. This delay, referred to as the induction period, can be days, weeks, months, or years. Toxic Reactions The chemical structures of some medications can lead to toxic reactions in certain organs of the body. Toxic chemical reactions can cause death, destruction, or changes to tissue (e.g., formation of deposits or discoloration). For example, topical use of epinephrine can form black deposits in the lower conjunctival sac inside the lid; Argyrol (a silver protein) can cause a graying of the conjunctiva. Some drugs can produce irreversible damage within the eye or cause systemic disturbances within the patient s body. Drug Reaction Prevention The single most effective way to avoid an adverse drug reaction in a patient is to take a good case history. Inquire about any drug sensitivities experienced in the past. If the patient had a reaction to sulfa drugs, it is foolish to administer them sulfacetamide to cure conjunctivitis. A patient with an anterior chamber intraocular lens placed in the eye may not react well to drops constricting or dilating the pupil excessively. Pupillary movement could displace the lens or cause the iris to become irritated from rubbing against the lens, possibly causing an iritis. Drug Reaction Prevention Find out if the patient is currently taking any other medications. If so, it s important to avoid using a drug that could cause a reaction with the other medication. If in doubt, it s always good practice to check with the doctor before administering anything. Wait between drops, you will reduce the risk of adverse interaction between the two different medications. In addition, eye drops will need this time to be absorbed completely and work effectively before the instillation of another drop. Things to Remember The actual drug name. Mydriacyl is a trade name for tropicamide, which is a cycloplegic,not a simple mydriatic. The drug percentage. Phenylephrine is phenylephrine, right? Wrong. The 2.5 percent dosage is a whole lot safer than the 10 percent version. You could literally kill someone by using the wrong type. If in doubt, double check with the doctor. The word ophthalmic (for use in the eyes). Some drugs you use on the eyes are also made for use on other parts of the body. For example, the antibiotic erythromycin is used on cuts and burns. If the tube doesn t say ophthalmic on it, the medication is not used in the eye. Only ophthalmic-quality drugs should be put in the eye. The manufacturer s expiration date. If the date stamped on the bottle or tube is JUNE 2018; do not use on 01 JULY 2018! 9

10 Things to Remember The date the medication was opened. If someone has already removed the manufacturer s seal and opened the drug, this person should have put the date the container was opened on the label. If a drug has been opened, but there is no date on it, throw it away. If it has been over 90 days since the drug was opened, throw it away. If the manufacturer s date has passed, but the drug was only opened 20 days ago, throw it away. ABBREVIATIONS If the drug container looks old or dirty, throw it away. Abbreviatio Meaning Abbreviatio n n Prescription abbreviations Meaning ac (ante cibum) before meals q (quaque) every ad lib (ad libitum) as much as wanted qd (quaque die) every day HOW TO WRITE AN Rx aq Water qh (quaque hora) every hour bid (bis in die) twice a day qid (quater in die) 4 times a day gt; gtt (gutta; guttae) drop; ql (quantum libet) as much as desired h hora) hour qqh or q4h (quaque quarta hora) every four hours hs (hora somni) at bedtime qs quantity sufficient mg Milligram Rx (recipe) prescription non rep (non repetatur) do not repeat Sol solution pc (post cibum) after meals Tid (ter in die) three times a day po (per os) by mouth, orally ung (unguentum) ointment Make sure that you include: Full name of patient Address can be optional Date of Rx Inscription: name of drug; concentration Subscription: amount to be dispensed Instructions: route of administration; number of drops or tablets; frequency of use; refill What else? Make sure that it is legible if you are writing in a chart! 10

11 References and resources THANK YOU! Ophthalmic Drug Facts 2002 Ophthalmic Medications and Pharmacology Review of Optometry: 2002 Clinical Guide to Ophthalmic Drugs (Melton and Thomas) May issue 11

PATIENT CASE HISTORY. General Health Medications Allergies

PATIENT CASE HISTORY. General Health Medications Allergies OCULAR PHARMACOLOGY What I Need to Know Before I Medicate A Patient Lynn Lawrence, CPOT, ABOC, COA ROLE of the ASSISTANT AND TECHNICIAN Accurate documentation/recording Patient Education can assist in

More information

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER Pilocarpine 2% w/v Eye Drops, solution Pilocarpine 4% w/v Eye Drops, solution Pilocarpine Hydrochloride (Referred to as Pilocarpine Eye Drops in this leaflet)

More information

PRESCRIBING INFORMATION MYDFRIN * Phenylephrine Hydrochloride Ophthalmic Solution. Vasoconstrictor and Mydriatic for Use in Ophthalmology

PRESCRIBING INFORMATION MYDFRIN * Phenylephrine Hydrochloride Ophthalmic Solution. Vasoconstrictor and Mydriatic for Use in Ophthalmology PRESCRIBING INFORMATION MYDFRIN * Phenylephrine Hydrochloride Ophthalmic Solution Vasoconstrictor and Mydriatic for Use in Ophthalmology Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd., Dorval,

More information

8 USE IN SPECIFIC POPULATIONS Patients with Open-Angle Glaucoma or Ocular Hypertension

8 USE IN SPECIFIC POPULATIONS Patients with Open-Angle Glaucoma or Ocular Hypertension 3 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Isopto Carpine safely and effectively. See full prescribing information for Isopto Carpine. Isopto

More information

OCULAR PHARMACOLOGY GLAUCOMA. increased intraocular pressure. normally mm Hg. when to Tx no fixed level.

OCULAR PHARMACOLOGY GLAUCOMA. increased intraocular pressure. normally mm Hg. when to Tx no fixed level. OCULAR PHARMACOLOGY GLAUCOMA increased intraocular pressure normally 12 20 mm Hg. when to Tx no fixed level. literature sets ~21 mm Hg as upper limit of normal. some safe at 30 mm Hg some may have damage

More information

Frequently Asked Questions about General Ophthalmology:

Frequently Asked Questions about General Ophthalmology: 1. Normal Eye Structure The eye is a slightly asymmetrical globe, about an inch in diameter. The parts of the eye include: Cornea (a clear dome over the iris), Iris (the pigmented part); Pupil (the black

More information

Assisting in Ophthalmology. Copyright 2011, 2007, 2003, 1999 by Saunders, an imprint of Elsevier Inc. All rights reserved.

Assisting in Ophthalmology. Copyright 2011, 2007, 2003, 1999 by Saunders, an imprint of Elsevier Inc. All rights reserved. Assisting in Ophthalmology Learning Objectives Define, spell, and pronounce the terms listed in the vocabulary. Apply critical thinking skills in performing patient assessment and care. Explain the differences

More information

Patient Information COSOPT PF (CO-sopt PEA EHF) (dorzolamide hydrochloride-timolol maleate ophthalmic solution) 2%/0.5%

Patient Information COSOPT PF (CO-sopt PEA EHF) (dorzolamide hydrochloride-timolol maleate ophthalmic solution) 2%/0.5% Patient Information COSOPT PF (CO-sopt PEA EHF) (dorzolamide hydrochloride-timolol maleate ophthalmic solution) 2%/0.5% Read this information before you start using COSOPT PF and each time you get a refill.

More information

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops Page 1 of 6 SCHEDULING STATUS Schedule 4 PATIENT INFORMATION LEAFLET PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops Read all of this leaflet carefully

More information

MAXITROL Eye Ointment

MAXITROL Eye Ointment MAXITROL Dexamethasone, Neomycin and Polymyxin B CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use Maxitrol. This leaflet answers some common questions

More information

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml) LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about LUMIGAN eye drops. It does not contain all the available

More information

What Maxitrol Eye Drops is used for

What Maxitrol Eye Drops is used for MAXITROL Dexamethasone, Neomycin and Polymyxin B CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use This leaflet answers some common questions about

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET SCHEDULING STATUS Schedule 4 Proprietary name, Strength and Pharmaceutical Form LUMIGAN 0,03 % Eye Drops (each ml contains bimatoprost 0,3 mg) Read all of this leaflet

More information

PRESCRIBING INFORMATION AND CONSUMER INFORMATION ISOPTO * CARPINE. pilocarpine hydrochloride ophthalmic solution, USP.

PRESCRIBING INFORMATION AND CONSUMER INFORMATION ISOPTO * CARPINE. pilocarpine hydrochloride ophthalmic solution, USP. PRESCRIBING INFORMATION AND CONSUMER INFORMATION Pr ISOPTO * CARPINE pilocarpine hydrochloride ophthalmic solution, USP 1%, 2% and 4% w/v Parasympathomimetic Alcon Canada Inc. 2665 Meadowpine Blvd. Mississauga,

More information

Ocular Anatomy for the Paraoptometric

Ocular Anatomy for the Paraoptometric Ocular Anatomy for the Paraoptometric Minnesota Optometric Association Paraoptometric CE Friday September 30, 2016 Lindsay A. Sicks, OD, FAAO Assistant Professor, Illinois College of Optometry lsicks@ico.edu

More information

SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM

SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM Page 1 of 5 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM FML Liquifilm Sterile Eye Suspension COMPOSITION FML Liquifilm Sterile Eye Suspension contains: Fluorometholone 1,0 mg/ml Liquifilm

More information

PATIENT GUIDE TO LUMIGAN 0.01%

PATIENT GUIDE TO LUMIGAN 0.01% Treatment Tracker enclosed PATIENT GUIDE TO LUMIGAN 0.01% LUMIGAN (bimatoprost ophthalmic solution) 0.01% is used for the treatment of high eye pressure, also called intraocular pressure (IOP), in people

More information

BETAGAN Allergan Levobunolol HCl Glaucoma Therapy

BETAGAN Allergan Levobunolol HCl Glaucoma Therapy BETAGAN Allergan Levobunolol HCl Glaucoma Therapy Action And Clinical Pharmacology: Levobunolol is a noncardioselective beta- adrenoceptor antagonist, equipotent at both beta1 and beta2 receptors. Levobunolol

More information

NEVANAC TM 0.1% Eye Drops

NEVANAC TM 0.1% Eye Drops NEVANAC TM 0.1% Eye Drops Nepafenac CONSUMER MEDICINE INFORMATION What is in this leaflet Please read this leaflet carefully before you use Nevanac Eye This leaflet answers some common questions about

More information

PRECISION PROGRAM. Injection Technique Quick-Reference Guide. Companion booklet for the Video Guide to Injection Technique

PRECISION PROGRAM. Injection Technique Quick-Reference Guide. Companion booklet for the Video Guide to Injection Technique Injection Technique Quick-Reference Guide PRECISION PROGRAM Companion booklet for the Video Guide to Injection Technique Available at www.ozurdexprecisionprogram.com Provides step-by-step directions with

More information

PRESCRIBING INFORMATION

PRESCRIBING INFORMATION PRESCRIBING INFORMATION OPTIMYXIN Gramicidin and Polymyxin B Sulfate Oto-Ophthalmic Solution sterile Eye/Ear Drops Antibiotic Sandoz Canada Inc. Date of Revision: November 25, 2015 145 Jules-Léger Boucherville,

More information

Package leaflet: Information for the user. Xalatan 50 micrograms/ml Eye drops, solution Latanoprost

Package leaflet: Information for the user. Xalatan 50 micrograms/ml Eye drops, solution Latanoprost Package leaflet: Information for the user Xalatan 50 micrograms/ml Eye drops, solution Latanoprost Read all of this leaflet carefully before you start using this medicine because it contains important

More information

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate Package leaflet: Information for the user PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate Read all of this leaflet carefully before you start using this medicine because it contains important

More information

PRESCRIBING INFORMATION WITH CONSUMER INFORMATION MYDRIACYL. tropicamide ophthalmic solution, USP. 0.5% and 1% w/v.

PRESCRIBING INFORMATION WITH CONSUMER INFORMATION MYDRIACYL. tropicamide ophthalmic solution, USP. 0.5% and 1% w/v. PRESCRIBING INFORMATION WITH CONSUMER INFORMATION Pr MYDRIACYL tropicamide ophthalmic solution, USP 0.5% and 1% w/v Anticholinergic Alcon Canada Inc. 2665 Meadowpine Blvd. Mississauga, ON L5N 8C7 www.alcon.ca

More information

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

2. QUALITATIVE AND QUANTITATIVE COMPOSITION NEW ZEALAND DATA SHEET 1. PRODUCT NAME MYDRIACYL (Tropicamide) 0.5% MYDRIACYL (Tropicamide) 1.0% Eye Drops 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of Mydriacyl Eye Drops contains the active

More information

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate Package leaflet: Information for the user PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate Read all of this leaflet carefully before you start using this medicine

More information

Glaucoma. Cornea. Iris

Glaucoma. Cornea. Iris Glaucoma Introduction Glaucoma is a group of eye diseases that can lead to blindness if not treated. Openangle glaucoma, the most common form of glaucoma, affects about 3 million Americans. Half of those

More information

PRODUCT INFORMATION. 2-(dimethylamino) ethyl (RS)-2-(1-hydroxycyclopentyl)-2- phenylacetate hydrochloride

PRODUCT INFORMATION. 2-(dimethylamino) ethyl (RS)-2-(1-hydroxycyclopentyl)-2- phenylacetate hydrochloride PRODUCT INFORMATION MINIMS CYCLOPENTOLATE EYE DROPS NAME OF THE MEDICINE Cyclopentolate hydrochloride Structural formula: Chemical name: Molecular formula: Molecular weight: 327.9 2-(dimethylamino) ethyl

More information

TOBREX TM EYE DROPS and EYE OINTMENT 0.3%

TOBREX TM EYE DROPS and EYE OINTMENT 0.3% TOBREX TM EYE DROPS and EYE OINTMENT 0.3% Tobramycin Consumer Medicine Information What is in this leaflet Read this leaflet carefully before you start to use Tobrex Eye Drops and Eye Ointment. This leaflet

More information

Eye Examination Techniques in Horses

Eye Examination Techniques in Horses Eye Examination Techniques in Horses Dennis E. Brooks DVM, PhD Dip ACVO University of Florida brooksd@mail.vetmed.ufl.edu Basic Instruments How to tell the potential of vision? PLRs (retina, CN 2, chiasm,

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET SCHEDULING STATUS Schedule 4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM PRED FORTE Sterile Eye Suspension, prednisolone acetate 10 mg/ml sterile eye suspension

More information

Scrub In. What is the function of vitreous humor? What does the pupil do when exposed to bright light? a. Maintain eye shape and provide color vision

Scrub In. What is the function of vitreous humor? What does the pupil do when exposed to bright light? a. Maintain eye shape and provide color vision Scrub In What is the function of vitreous humor? a. Maintain eye shape and provide color vision b. Maintain eye shape and refract light rays c. Provide night vision and color vision d. Provide night vision

More information

Proposed PIL NL/H/0653/001/IB/024/G. MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate

Proposed PIL NL/H/0653/001/IB/024/G. MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate Proposed PIL NL/H/0653/001/IB/024/G PACKAGE LEAFLET: INFORMATION FOR THE USER MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate Read all of this leaflet

More information

MAXIDEX TM Eye Ointment 0.1%

MAXIDEX TM Eye Ointment 0.1% MAXIDEX TM Eye Ointment 0.1% Dexamethasone CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use Maxidex Eye Ointment. This leaflet answers some common

More information

ENIDIN EYE DROPS [brimonidine tartrate]

ENIDIN EYE DROPS [brimonidine tartrate] ENIDIN EYE DROPS [brimonidine tartrate] Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ENIDIN eye drops, including how to use the eye It does not

More information

TENTATIVE DIAGNOSES Based on the information provided so far, what are the potential diagnoses?

TENTATIVE DIAGNOSES Based on the information provided so far, what are the potential diagnoses? Kallendorf-Case Study #4 PEDIATRIC CASE STUDY SCENARIO Mary Jennings has brought her son Joe to your office. Joe is a 6-year old Jordanian male. He presents with the complaint of an itchy red eye. Mary

More information

New Zealand Data Sheet

New Zealand Data Sheet New Zealand Data Sheet Prednisolone-AFT 1% Prednisolone acetate (Ph Eur) 1% w/v ophthalmic suspension Presentation Prednisolone-AFT 1% is a milky white suspension in an eyedropper bottle for ophthalmic

More information

Glaucoma. What is glaucoma? Eye Words to Know. What causes glaucoma?

Glaucoma. What is glaucoma? Eye Words to Know. What causes glaucoma? 2014 2015 Glaucoma What is glaucoma? Glaucoma is a disease that damages your eye s optic nerve. It usually happens when fluid builds up in the front part of your eye. That extra fluid increases the pressure

More information

Get a grip on your glaucoma Booklet 1

Get a grip on your glaucoma Booklet 1 Information for Patients Glaucoma services Welcome! Get a grip on your glaucoma Booklet 1 Group-based Glaucoma information Course Session 1 What happens in session 1? Finding out what questions you have

More information

02/03/2014. Average Length: 23mm (Infant ~16mm) Approximately the size of a quarter Volume: ~5mL

02/03/2014. Average Length: 23mm (Infant ~16mm) Approximately the size of a quarter Volume: ~5mL Identify the anatomy of the eye. Explain the basic physiology of the parts of the eye. Briefly discuss various surgeries related to different parts of the anatomy. Average Length: 23mm (Infant ~16mm) Approximately

More information

APO-Latanoprost Contains the active ingredient latanoprost

APO-Latanoprost Contains the active ingredient latanoprost APO-Latanoprost Contains the active ingredient latanoprost Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet Read this leaflet carefully before

More information

TOBRADEX TM Eye Drops

TOBRADEX TM Eye Drops TOBRADEX TM Eye Drops Tobramycin and Dexamethasone CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use Tobradex Eye This leaflet answers some common

More information

GLAUCOMA. An Overview

GLAUCOMA. An Overview GLAUCOMA An Overview Compiled by Campbell M Gold (2004) CMG Archives http://campbellmgold.com --()-- IMPORTANT The health information contained herein is not meant as a substitute for advice from your

More information

Dorzolamide 20 mg/ml Eye Drops, Solution

Dorzolamide 20 mg/ml Eye Drops, Solution PACKAGE LEAFLET: INFORMATION FOR THE USER Dorzolamide 20 mg/ml Eye Drops, Solution (Dorzolamide hydrochloride) Read all of this leaflet carefully before you start using this medicine because it contains

More information

Unit6. Prescriptions. Speaking:Giving A Prescription. Vocabulary: Common Latin Rx Terms. Articles: A Prescription: Understanding.

Unit6. Prescriptions. Speaking:Giving A Prescription. Vocabulary: Common Latin Rx Terms. Articles: A Prescription: Understanding. Unit6 Prescriptions Grammar: The Future: Will\ Going to Expressing the Future in Time Clauses Using the Present Progressive and Simple Present to Express Future Time Future Progressive Speaking:Giving

More information

Glaucoma. Glaucoma. Glaucoma. Trevor Arnold, MS, DVM, DACVO

Glaucoma. Glaucoma. Glaucoma. Trevor Arnold, MS, DVM, DACVO Glaucoma Trevor Arnold, MS, DVM, DACVO Glaucoma Physiology of Aqueous Humor Produced in the ciliary body Flows out the iridocorneal angle and ciliary cleft High intraocular pressures are caused by a decreased

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP Read this carefully before you start taking IOPIDINE 1% and each

More information

TENOPT timolol maleate

TENOPT timolol maleate TENOPT timolol maleate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all the available information. It does not take the place

More information

ACULAR EYE DROPS 5 mg/ml Eye Drops

ACULAR EYE DROPS 5 mg/ml Eye Drops ACULAR EYE DROPS 5 mg/ml Eye Drops (ketorolac trometamol) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ACULAR eye drops, including how to use the

More information

TENTATIVE DIAGNOSES Based on the information provided so far, what are the potential diagnoses?

TENTATIVE DIAGNOSES Based on the information provided so far, what are the potential diagnoses? Case Study #4 PEDIATRIC CASE STUDY SCENARIO Mary Jennings has brought her son Joe to your office. Joe is a 6-year old Jordanian male. He presents with the complaint of an itchy red eye. Mary states that

More information

UC SF. g h. Eye Trauma. Martha Neighbor, MD Emergency Services San Francisco General Hospital University of California

UC SF. g h. Eye Trauma. Martha Neighbor, MD Emergency Services San Francisco General Hospital University of California UC SF Eye Trauma sf g h Martha Neighbor, MD Emergency Services San Francisco General Hospital University of California Goals Recognize vision threatening eye emergencies Treat them when we can Know when

More information

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost Package Leaflet: Information for the user LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost Read all of this leaflet carefully before you start using this medicine because it

More information

OPHTHALMOLOGIC PEARLS FOR THE NON- OPHTHALMOLOGIST. David G. Gross D.O. Deen-Gross Eye Centers Merrillville-Hobart Deengrosseye.

OPHTHALMOLOGIC PEARLS FOR THE NON- OPHTHALMOLOGIST. David G. Gross D.O. Deen-Gross Eye Centers Merrillville-Hobart Deengrosseye. OPHTHALMOLOGIC PEARLS FOR THE NON- OPHTHALMOLOGIST David G. Gross D.O. Deen-Gross Eye Centers Merrillville-Hobart Deengrosseye.com A FEW OF THE AREAS WE WILL DISCUSS Red Eye Glaucoma Neuro ophthalmic tid

More information

Elements for a Public Summary. Overview of disease epidemiology

Elements for a Public Summary. Overview of disease epidemiology VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Epidemiology of the disease Incidence and prevalence Increased pressure in the eye occurs in more than 100 million people, and

More information

FAIRFIELD SCHOOL HEALTH PROGRAM. PROCEDURE: Administration of Oral, Topical or Inhalant Medications by Principals and Teachers

FAIRFIELD SCHOOL HEALTH PROGRAM. PROCEDURE: Administration of Oral, Topical or Inhalant Medications by Principals and Teachers FAIRFIELD SCHOOL HEALTH PROGRAM PROCEDURE: Administration of Oral, Topical or Inhalant Medications by Principals and Teachers 1. Obtain key Access to all stored medications is limited to persons authorized

More information

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution Levofloxacin Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

2. QUALITATIVE AND QUANTITATIVE COMPOSITION NEW ZEALAND DATA SHEET 1. PRODUCT NAME ISOPTO CARPINE pilocarpine hydrochloride eye drops 1% ISOPTO CARPINE pilocarpine hydrochloride eye drops 2% ISOPTO CARPINE pilocarpine hydrochloride eye drops 4%

More information

Acute Eyes for ED. Enis Kocak. The Alfred Ophthalmology

Acute Eyes for ED. Enis Kocak. The Alfred Ophthalmology Acute Eyes for ED Enis Kocak The Alfred Ophthalmology The problem with eyes Things to cover Ocular anatomy Basic assessment Common presentations Eye first aid and procedures Ophthalmic emergencies What

More information

Ophthalmological preparations

Ophthalmological preparations Ophthalmological preparations Administration of eye preparations Preparations for the eye should be sterile when issued. Use of single-application containers is preferable; multiple-application preparations

More information

CORNEAL CONDITIONS CORNEAL TRANSPLANTATION

CORNEAL CONDITIONS CORNEAL TRANSPLANTATION GENERAL INFORMATION CORNEAL CONDITIONS CORNEAL TRANSPLANTATION WHAT ARE CORNEAL CONDITIONS? The cornea is the clear outer layer of the eye. Shaped like a dome, it helps to protect the eye from foreign

More information

Divakar Gupta Glaucoma Fellow, Duke Eye Center 5/14/16

Divakar Gupta Glaucoma Fellow, Duke Eye Center 5/14/16 Divakar Gupta Glaucoma Fellow, Duke Eye Center 5/14/16 Pathophysiology of glaucoma Consider risk factors of glaucoma Understand the side effects of glaucoma medications Diagnostic testing Leading cause

More information

THE CHRONIC GLAUCOMAS

THE CHRONIC GLAUCOMAS THE CHRONIC GLAUCOMAS WHAT IS GLAUCOMA? People with glaucoma have lost some of their field of all round vision. It is often the edge or periphery that is lost. That is why the condition can be missed until

More information

INDICATIONS ACULAR 0,4% ophthalmic solution is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery.

INDICATIONS ACULAR 0,4% ophthalmic solution is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery. Page 1 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME (and dosage form) ACULAR 0,4% COMPOSITION ACULAR 0,4% ophthalmic solution contains: Ketorolac tromethamine: 4 mg/ml Preservative: Benzalkonium chloride

More information

How to Manage Medications Caregiving Series

How to Manage Medications Caregiving Series How to Manage Medications Caregiving Series Objectives Upon completion of this training, the participant will: Learn the warning signs of improper medication use Have an understanding of how aging changes

More information

EYE INJURIES OBJECTIVES COMMON EYE EMERGENCIES 7/19/2017 IMPROVE ASSESSMENT OF EYE INJURIES

EYE INJURIES OBJECTIVES COMMON EYE EMERGENCIES 7/19/2017 IMPROVE ASSESSMENT OF EYE INJURIES EYE INJURIES BRITTA ANDERSON D.O. DMC PRIMARY CARE SPORTS MEDICINE ASSOCIATE TEAM PHYSICIAN DETROIT TIGERS OBJECTIVES IMPROVE ASSESSMENT OF EYE INJURIES UNDERSTAND WHAT IS CONSIDERED AN EMERGENCY DEVELOP

More information

MAXIDEX Eye Drops 0.1%

MAXIDEX Eye Drops 0.1% MAXIDEX Eye Drops 0.1% Dexamethasone CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use Maxidex Eye Drops. This leaflet answers some common questions

More information

Uveitis. Pt Info Brochure. Q: What is Uvea?

Uveitis. Pt Info Brochure. Q: What is Uvea? Pt Info Brochure Uveitis Q: What is Uvea? A: Uvea is the middle layer of the eye. It is the most vascular structure of the eye. It provides nutrition to the other parts of the eye. The uvea is made up

More information

Package leaflet: Information for the user. Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost

Package leaflet: Information for the user. Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost Package leaflet: Information for the user Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost Read all of this leaflet carefully before you start using this medicine because it contains

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. T-LO Timolol Ophthalmic Solution (0.25%, 0.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. T-LO Timolol Ophthalmic Solution (0.25%, 0. READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr T-LO Timolol Ophthalmic Solution (0.25%, 0.5% w/v) Pr TIMOLOL MALEATE-EX Timolol Ophthalmic Gel Forming Solution

More information

9/23/2014. Emily Thomas, O.D. MOA Paraoptometric Education October 5, 2014

9/23/2014. Emily Thomas, O.D. MOA Paraoptometric Education October 5, 2014 Emily Thomas, O.D. MOA Paraoptometric Education October 5, 2014 Anterior toward the front of the body Posterior toward the rear of the body Unilateral only one eye involved Bilateral both eyes involved

More information

VI.2.2 Summary of treatment benefits

VI.2.2 Summary of treatment benefits EU-Risk Management Plan for Bimatoprost V01 aetiology), both OAG and ACG can be secondary conditions. Secondary glaucoma refers to any case in which another disorder (e.g. injury, inflammation, vascular

More information

MAXITROL* Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0.

MAXITROL* Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0. PRESCRIBING INFORMATION Pr MAXITROL* Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0.1% w/w Pr MAXITROL* Neomycin and Polymyxin B

More information

Chemical Name: 4H-Pyrano[3,2-g]quinoline-2,8-dicarboxylic acid, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-, disodium salt.

Chemical Name: 4H-Pyrano[3,2-g]quinoline-2,8-dicarboxylic acid, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-, disodium salt. ALCRIL (nedocromil sodium ophthalmic solution) 2% sterile DESCRIPTIN ALCRIL (nedocromil sodium ophthalmic solution) 2% is a clear, yellow, sterile solution for topical ophthalmic use. Nedocromil sodium

More information

INDICATIONS ACULAR 0,5 % is indicated for the relief of inflammation following ocular surgery.

INDICATIONS ACULAR 0,5 % is indicated for the relief of inflammation following ocular surgery. Page 1 of 5 SCHEDULING STATUS Schedule 3 PROPRIETARY NAME (AND DOSAGE FORM) ACULAR 0,5 % COMPOSITION ACULAR 0,5 % contains: Preservatives: Benzalkonium chloride 0,01 % m/v Disodium edetate 0,1 % m/v PHARMACOLOGICAL

More information

Medications. Managing and Administering Medication

Medications. Managing and Administering Medication Medications Managing and Administering Medication The Medication Administration Checklist Administering medications is an important and vital responsibility. It is important to make sure that no errors

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol) PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol) Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may

More information

Ophthalmology Department. 2009, The Permanente Medical Group, Inc. All rights reserved, Ophthalmology Department.

Ophthalmology Department. 2009, The Permanente Medical Group, Inc. All rights reserved, Ophthalmology Department. Glaucoma: Title of article Trabeculectomy is Ahmed positioned Valve here POST-SURGICAL SUB TITLE POSITIONED INSTRUCTIONS HERE These instructions are for patients recovering from one of the following eye

More information

A Guide to Administering

A Guide to Administering A Guide to Administering INDICATIONS AND USAGE YUTIQ (fluocinolone acetonide intravitreal implant) 0.18 mg is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment

More information

Phospholine Iodide (echothiophate iodide for ophthalmic solution)

Phospholine Iodide (echothiophate iodide for ophthalmic solution) Phospholine Iodide (echothiophate iodide for ophthalmic solution) Rx Only DESCRIPTION Chemical name: (2-mercaptoethyl) trimethylammonium iodide O,O-diethyl phosphorothioate Structural formula Echothiophate

More information

NORTHEAST OHIO NEIGHBORHOOD HEALTH SERVICES, INC. OPTOMETRIC MEDICINE CLINICAL GUIDELINES: TABLE OF CONTENTS

NORTHEAST OHIO NEIGHBORHOOD HEALTH SERVICES, INC. OPTOMETRIC MEDICINE CLINICAL GUIDELINES: TABLE OF CONTENTS NORTHEAST OHIO NEIGHBORHOOD HEALTH SERVICES, INC. OPTOMETRIC MEDICINE CLINICAL GUIDELINES: 2012-2013 TABLE OF CONTENTS CONDITION PAGE(S) Complete Eye and Vision Examination 2 Vision Screening Procedure

More information

BrinzoQuin Eye Drops 1.0%

BrinzoQuin Eye Drops 1.0% BrinzoQuin Eye Drops 1.0% Brinzolamide Consumer Medicine Information What Is In This Leaflet Read this leaflet carefully before you start to use BrinzoQuin Eye Drops. This leaflet has been written to answer

More information

WORLD GLAUCOMA WEEK What is Glaucoma? Can I develop glaucoma if I have increased eye pressure?

WORLD GLAUCOMA WEEK What is Glaucoma? Can I develop glaucoma if I have increased eye pressure? WORLD GLAUCOMA WEEK What is Glaucoma? Glaucoma is a group of diseases that damage the optic nerve and can result in gradual vision loss and blindness. However, with early detection and treatment, you can

More information

Flashers and Floaters

Flashers and Floaters Flashers and Floaters Introduction Sometimes people see small, moving spots or specks in their field of vision. These sensations are called floaters. About 7 out of 10 people experience floaters at some

More information

PRODUCT INFORMATION. Bis[(1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2RS)-3- hydroxy-2-phenylpropanoate] sulfate monohydrate

PRODUCT INFORMATION. Bis[(1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2RS)-3- hydroxy-2-phenylpropanoate] sulfate monohydrate PRODUCT INFORMATION MINIMS ATROPINE EYE DROPS NAME OF THE MEDICINE Atropine sulphate Structural formula: Chemical name: Molecular formula: Molecular weight: 694.8 CAS number: DESCRIPTION Bis[(1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl

More information

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate Package leaflet: Information for the patient Brimonidine Biogaran 2 mg/ml eye drops, solution brimonidine tartrate Read all of this leaflet carefully before you start using this medicine because it contains

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone

PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You

More information

Ocular and periocular trauma

Ocular and periocular trauma Ocular and periocular trauma No financial disclosures. Tina Rutar M.D. Assistant Professor of Clinical Ophthalmology and Pediatrics Director, Visual Center for the Child University of California San Francisco

More information

Dry Eye Assessment and Management Study ELIGIBILITY OCULAR EVALUATION FORM

Dry Eye Assessment and Management Study ELIGIBILITY OCULAR EVALUATION FORM Page 1 of 13 BEFORE COMPLETING THE OCULAR EXAMINATION, YOU MUST BE ABLE TO ANSWER YES TO THE FOLLOWING QUESTIONS: Have you done MMP9? (SVonly) The Following are done at Baseline: Have you done Tear Osmolarity?

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET Page 1 PATIENT INFORMATION LEAFLET Please read this leaflet carefully before using COMBIGAN. Keep this leaflet. You may need to read it again. If you have any further questions, please ask your doctor

More information

Package leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin

Package leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin Package leaflet: Information for the user 3 mg/ml eye drops, solution Ofloxacin Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

More information

PRODUCT INFORMATION ALCAINE. Proparacaine Hydrochloride Sterile Ophthalmic Solution, USP. 5 mg/ml. Topical Anesthetic

PRODUCT INFORMATION ALCAINE. Proparacaine Hydrochloride Sterile Ophthalmic Solution, USP. 5 mg/ml. Topical Anesthetic PRODUCT INFORMATION ALCAINE Proparacaine Hydrochloride Sterile Ophthalmic Solution, USP 5 mg/ml Topical Anesthetic Alcon Canada Inc. 2665 Meadowpine Blvd. Mississauga, ON L5N 8C7 www.alcon.ca Date of Preparation:

More information

INDICATIONS For steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye globe.

INDICATIONS For steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye globe. Page 1 of 5 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM PRED FORTE Sterile Eye Suspension COMPOSITION PRED FORTE Sterile Eye Suspension contains: Prednisolone acetate 10 mg/ml Preservative:

More information

YOUR VYZULTA TREATMENT GUIDE. Please see Important Safety Information on pages 1, 9, 10, 17 and 18. Please see accompanying Prescribing Information.

YOUR VYZULTA TREATMENT GUIDE. Please see Important Safety Information on pages 1, 9, 10, 17 and 18. Please see accompanying Prescribing Information. YOUR VYZULTA TREATMENT GUIDE Please see Important Safety Information on pages 1, 9, 10, 17 and 18. Please see accompanying Prescribing Information. INDICATION VYZULTA TM (latanoprostene bunod ophthalmic

More information

Sepideh Tara Rousta, MD FAAO Robert Wood Johnson University Hospital Saint Peter s University Hospital Wills Eye Hospital

Sepideh Tara Rousta, MD FAAO Robert Wood Johnson University Hospital Saint Peter s University Hospital Wills Eye Hospital Sepideh Tara Rousta, MD FAAO Robert Wood Johnson University Hospital Saint Peter s University Hospital Wills Eye Hospital 14 mo old w R eye cross (parents) 9 mo old R eye crossing getting worse for past

More information

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone Package Leaflet - Information for the User TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone Read all of this leaflet carefully before you start using this medicine because it

More information

Elements for a public summary. VI.2.1 Overview of disease epidemiology

Elements for a public summary. VI.2.1 Overview of disease epidemiology VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology The term ocular hypertension usually refers to any situation in which the pressure inside the eye, called intraocular pressure,

More information

Treatments for Open-Angle Glaucoma. A Review of the Research for Adults

Treatments for Open-Angle Glaucoma. A Review of the Research for Adults Treatments for Open-Angle Glaucoma A Review of the Research for Adults Is This Information Right for Me? Yes, this information is for you if: Your eye doctor has said that you have open-angle glaucoma,

More information

An Injector s Guide to OZURDEX (dexamethasone intravitreal implant) 0.7 mg

An Injector s Guide to OZURDEX (dexamethasone intravitreal implant) 0.7 mg An Injector s Guide to OZURDEX (dexamethasone intravitreal implant) 0.7 mg This guide is intended to provide injectors with information on the recommended injection technique and the important risks related

More information

Summary of the risk management plan (RMP) for Omidria (phenylephrine / ketorolac)

Summary of the risk management plan (RMP) for Omidria (phenylephrine / ketorolac) EMA/368070/2015 Summary of the risk management plan (RMP) for Omidria (phenylephrine / ketorolac) This is a summary of the risk management plan (RMP) for Omidria, which details the measures to be taken

More information